Publications by authors named "I Zarcos-Pedrinaci"
Article Synopsis
- * It utilized a large sample of 2602 CRC patients, using the Hospital Anxiety and Depression Scale for measurement and analyzing survival data with advanced statistical methods.
- * Results indicated that depression significantly increases the risk of poor survival outcomes, suggesting the need for regular screening and treatment of depressive symptoms in CRC patients to improve their overall prognosis.
Article Synopsis
- Colorectal cancer affects both men and women, and diagnosis can be delayed due to various factors like absence of symptoms or lack of screening tests.
- A study involving 1,688 patients across 22 Spanish hospitals aimed to assess whether delayed diagnosis impacts overall survival at five years.
- Results showed that a diagnostic delay of more than 30 days did not worsen prognosis, while delays less than 30 days were linked to shorter survival, suggesting that quicker diagnoses are often related to more severe cases.
Goals of endocrine therapy for advanced breast cancer (ABC) include prolonging survival rates, maintaining the quality of life, and delaying the initiation of chemotherapy. We evaluated the effectiveness of fulvestrant as first-line in patients with estrogen receptor (ER)-positive ABC with relapse during or after adjuvant anti-estrogenic therapy in real-world settings. Retrospective, observational study involving 171 postmenopausal women with ER-positive ABC who received fulvestrant as first-line between January 2011 and May 2018 in Spanish hospitals.
View Article and Find Full Text PDFIntroduction: The diagnosis or treatment of breast cancer is sometimes delayed. A lengthy delay may have a negative psychological impact on patients. The aim of our study was to evaluate the sociodemographic, clinical and pathological factors associated with delay in the provision of surgical treatment for localised breast cancer, in a prospective cohort of patients.
View Article and Find Full Text PDFThe aim of this study is to determine the survival of patients with breast cancer treated with adjuvant chemotherapy (ACh) after the diagnosis by screening, taking comorbidity into account. This multicenter cohort study examined a population of patients taking part in four national screening programs for the early detection of breast cancer (localized or locally advanced), during the period 2000-2008. Of the 1248 cancers detected, 266 were prevalent (21.
View Article and Find Full Text PDF